CRH plc

CRH Basic Materials · Building Materials
Delayed 15 min
Last close
$82.32
Oct 16, 2026
52-week range
$78.62 — $131.55
-37% from high
Market cap
54.8B
Diluted basis
Dividend yield
1.9%
P/E
14.5
Trailing
Verdict status · Oct 16, 2026

Not yet scored

Filing.fyi has not computed forensic scores for CRH yet. Scores appear after the company's next data refresh.

No verdict yet
RED DEEP Scores pending shown after the next data refresh
Composite Health
AI synthesis · written from this company's SEC filings · not investment advice

What the filing actually says.

AI · forensic preset

The reported figures show steady growth across the five fiscal years provided. Revenue rose from $29.21 billion in 2021 to $37.45 billion in 2025, and operating income rose every year, from $3.33 billion to $5.44 billion. Net income does not follow the same path. It peaked at $3.86 billion in 2022, fell to $3.18 billion in 2023, and then recovered to $3.75 billion in 2025. The gap between operating income and net income is also worth noting. In 2023, operating income was $4.19 billion while net income was $3.18 billion, a difference of about $1.01 billion. In 2022, net income was slightly higher than operating income. The data provided does not show what caused these gaps, such as taxes, interest, or other items, so a reader cannot determine their cause from this data alone. The balance sheet also has a reconciling difference. Assets exceed the sum of liabilities and equity by $1.48 billion in 2025 and $1.24 billion in 2024. The data does not explain this difference, and readers may want to look at how the full filing presents noncontrolling interests and other equity items. No Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index values are on file, so this synthesis does not characterize any of them. The MD&A, risk-factor text, and news are also not on file, so the company's segments, products, legal matters, and regulatory exposures cannot be named or assessed here. The figures show growth in revenue, operating income, and net income, alongside a faster rise in liabilities than in equity. Those are the points a careful reader can verify directly in the filing, and the narrative sections are needed to interpret them.

Catalyst.The annual figures show revenue of $37.45 billion in 2025, up from $35.57 billion in 2024, a rise of about 5.3 percent. Operating income increased about 10.6 percent, from $4.92 billion to $5.44 billion, and net income rose about 7.5 percent, from $3.49 billion to $3.75 billion. Operating income as a share of revenue moved from about 13.8 percent to about 14.5 percent. The MD&A text that would explain what drove these results is not on file for this analysis, so the cause of the change is not attributed here.

Hidden risk.The most visible tension in the numbers is balance-sheet growth. Total liabilities rose from $27.76 billion to $32.85 billion, about 18.3 percent, while equity rose from $21.61 billion to $24 billion, about 11.1 percent. Liabilities now run about 1.37 times equity, compared with about 1.28 times in 2024. Total assets grew about 15.3 percent over the same year. Because risk-factor text is not on file, the debt instruments, maturities, and covenants behind this increase cannot be examined here, and readers may want to look at the debt and liabilities notes in the full filing.

Market signals · from trading data, not filings

What traders are betting.

The scores above come from what CRH reports to the SEC. These readings come from how traders are positioned in its shares. They change quickly, they can be wrong, and they are not part of the verdict.
Short interest Shares sold short · reported twice a month
2.2%
of the shares available to trade
Low
0%5% · 10% · 20%25%+

The metric

Shares that traders have borrowed and sold, betting the price will fall, and not yet bought back. Brokers report the total to FINRA twice a month. Days to cover divides it by the shares that change hands on a typical day.

Shares sold short
12.6M
Change since Aug 31
−0.6%
Days to cover
2.3

What it tells us

Few traders are betting against CRH. Levels this low are common for large, widely held companies.

Little changed since the Aug 31 report (−0.6%).

At normal trading volume, short sellers would need about 2.3 days to buy back every borrowed share.

How investors use it

  • Squeeze watching. Some aggressive traders seek out heavily shorted stocks, betting that good news will force short sellers to buy back shares and push the price higher.
  • Hedging. Funds short one company to offset risk in another, often owning a stronger business and shorting a weaker one in the same industry.
  • Timing. Chart-based traders pair rising short interest with price patterns, such as a break below a level where buyers used to step in, to decide when to enter or exit.
  • Warning sign. Some owners treat a sharp rise in short interest as a red flag and respond by tightening stop-loss orders or holding smaller positions.

Lesson: short interest, explained →

Short-interest report for Sep 30, 2026, via Yahoo Finance. Reports come out about a week and a half after that date.

SEC filings · last 12 months

Quarterly report

The quarterly report (10-Q) and current reports (8-K) CRH filed in the last 12 months, each linked to the original document on SEC EDGAR.

  • Jul 30, 2026
    10-Q
    Quarterly report0
    EDGAR →
  • Jul 30, 2026
    8-K
    Current reportItem 2.02: Results of operations (earnings)0
    EDGAR →
  • Jul 17, 2026
    8-K
    Current reportItem 8.01: Other events0
    EDGAR →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →